Filing Details
- Accession Number:
- 0001209191-19-049546
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-13 20:01:41
- Reporting Period:
- 2019-09-11
- Accepted Time:
- 2019-09-13 20:01:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277462 | Karen Gibson | 12544 High Bluff Drive, Suite 200 San Diejo CA 92130 | Svp, Is & Bus. Transformation | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-11 | 14,354 | $25.55 | 19,545 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-09-11 | 14,354 | $68.61 | 5,191 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-09-13 | 4,527 | $67,515.00 | 759 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-09-11 | 14,354 | $0.00 | 14,354 | $25.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-04-06 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $68.6136 per share, with a range of $68.34 to $69.06. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $67.515 per share, with a range of $67.285 to $67.845. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The amount of securities beneficially owned following this transaction includes an additional 95 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
- 7,178 shares vested on 04/06/2017; 3,588 shares vested on 04/06/2018; and 3,588 shares vested on 04/06/2019.
Billionaire Hedge Funds
